BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19060230)

  • 1. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.
    Mercer PF; Johns RH; Scotton CJ; Krupiczojc MA; Königshoff M; Howell DC; McAnulty RJ; Das A; Thorley AJ; Tetley TD; Eickelberg O; Chambers RC
    Am J Respir Crit Care Med; 2009 Mar; 179(5):414-25. PubMed ID: 19060230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-κB and activator protein-1.
    Deng X; Xu M; Yuan C; Yin L; Chen X; Zhou X; Li G; Fu Y; Feghali-Bostwick CA; Pang L
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1366-76. PubMed ID: 23583295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
    Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
    Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
    Howell DC; Johns RH; Lasky JA; Shan B; Scotton CJ; Laurent GJ; Chambers RC
    Am J Pathol; 2005 May; 166(5):1353-65. PubMed ID: 15855637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathways.
    Deng X; Mercer PF; Scotton CJ; Gilchrist A; Chambers RC
    Mol Biol Cell; 2008 Jun; 19(6):2520-33. PubMed ID: 18353977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.
    Garcia O; Carraro G; Turcatel G; Hall M; Sedrakyan S; Roche T; Buckley S; Driscoll B; Perin L; Warburton D
    PLoS One; 2013; 8(8):e71679. PubMed ID: 23967234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis.
    Baran CP; Opalek JM; McMaken S; Newland CA; O'Brien JM; Hunter MG; Bringardner BD; Monick MM; Brigstock DR; Stromberg PC; Hunninghake GW; Marsh CB
    Am J Respir Crit Care Med; 2007 Jul; 176(1):78-89. PubMed ID: 17431224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
    Scotton CJ; Krupiczojc MA; Königshoff M; Mercer PF; Lee YC; Kaminski N; Morser J; Post JM; Maher TM; Nicholson AG; Moffatt JD; Laurent GJ; Derian CK; Eickelberg O; Chambers RC
    J Clin Invest; 2009 Sep; 119(9):2550-63. PubMed ID: 19652365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.
    Sun L; Louie MC; Vannella KM; Wilke CA; LeVine AM; Moore BB; Shanley TP
    Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L341-53. PubMed ID: 21131395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis.
    Yang J; Agarwal M; Ling S; Teitz-Tennenbaum S; Zemans RL; Osterholzer JJ; Sisson TH; Kim KK
    Am J Respir Cell Mol Biol; 2020 May; 62(5):622-632. PubMed ID: 31922885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
    Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
    Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAR-1-dependent and PAR-independent pro-inflammatory signaling in human lung fibroblasts exposed to thrombin.
    Ortiz-Stern A; Deng X; Smoktunowicz N; Mercer PF; Chambers RC
    J Cell Physiol; 2012 Nov; 227(11):3575-84. PubMed ID: 22278285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling.
    Zhu Z; Ma B; Zheng T; Homer RJ; Lee CG; Charo IF; Noble P; Elias JA
    J Immunol; 2002 Mar; 168(6):2953-62. PubMed ID: 11884467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.
    Borensztajn K; Bresser P; van der Loos C; Bot I; van den Blink B; den Bakker MA; Daalhuisen J; Groot AP; Peppelenbosch MP; von der Thüsen JH; Spek CA
    Am J Pathol; 2010 Dec; 177(6):2753-64. PubMed ID: 20971733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation.
    Mercer PF; Williams AE; Scotton CJ; José RJ; Sulikowski M; Moffatt JD; Murray LA; Chambers RC
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):144-57. PubMed ID: 23972264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
    Howell DC; Goldsack NR; Marshall RP; McAnulty RJ; Starke R; Purdy G; Laurent GJ; Chambers RC
    Am J Pathol; 2001 Oct; 159(4):1383-95. PubMed ID: 11583966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2.
    Kalderén C; Forsgren M; Karlström U; Stefansson K; Svensson R; Berglund MM; Palm G; Selander M; Sundbom M; Nilsson J; Sjögren A; Zachrisson K; Gelius SS
    Biochem Pharmacol; 2012 Mar; 83(5):644-52. PubMed ID: 22177985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury.
    Mercer PF; Deng X; Chambers RC
    Ann N Y Acad Sci; 2007 Jan; 1096():86-8. PubMed ID: 17405919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.